CelTOS antigen vaccine, GLA-SE adjuvanted (Infectious Disease Research Institute)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCelTOS antigen vaccine, GLA-SE adjuvanted (Infectious Disease Research Institute)
Drug Alias NameFMP-012/GLA-SE
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMalaria
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMalaria
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A